Distribution of company announcements to the professional platforms, finance portals and syndication of important corporate news to a wide variety of news aggregators and financial news systems.
H. Lundbeck On 31 July 2008, H. Lundbeck A/S was notified that LFI A/S (the Lundbeck Foundation) after today's registered change of the H. Lundbeck A/S' share capital holds 69.7621% of the shares in Lundbeck corresponding to 137,351,918 shares.
Lundbeck contacts
Investors: Media:
Jacob Tolstrup Mads Vindahl Kronborg Director Media Relations +45 36 43 30 79 +45 36 43 28 51
Palle Holm Olesen Head of Investor Relations +45 36 43 24 26
Release No 351 - 31 July 2008
About Lundbeck H. Lundbeck A/S is an international pharmaceutical company engaged in the research and development, production, marketing and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders. In 2007, the company's revenue was DKK 11 billion (approximately EUR 1.6 billion or USD 2.0 billion). The number of employees is approx. 5,300 globally. For more information, please visit www.lundbeck.com.
